About ProMetic Life Sciences
Prometic Life Sciences Inc (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and Protein Technology. The Company offers its technology platform for large-scale drug purification of biologics, drug development, proteomics and the elimination of pathogens to various industries, and uses its own affinity technology that provides for extraction and purification of therapeutic proteins from human plasma in order to develop therapeutics and orphan drugs. ProMetic is also developing its own small molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. It has research and development facilities in the United Kingdom, the United States and Canada; manufacturing facilities in the Isle of Man and Canada, and business development activities in the United States, Europe and Asia.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: TSE
- Symbol: PLI
- Previous Close: $2.38
- 50 Day Moving Average: $2.22
- 200 Day Moving Average: $2.54
- 52-Week Range: C$620,562,000.00 - C$1.47
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $1.40B
- Outstanding Shares: 620,562,000
Earnings History for ProMetic Life Sciences (TSE:PLI)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for ProMetic Life Sciences (TSE:PLI)
Current Year EPS Consensus Estimate: $-0.13 EPS
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for ProMetic Life Sciences (TSE:PLI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for ProMetic Life Sciences (TSE:PLI)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/7/2016||Simon Geoffrey Best||Director||Buy||2,750||C$2.93||C$8,057.50|
|1/21/2016||Raymond Manuel Hakim||Director||Buy||10,000||C$2.77||C$27,700.00|
|12/31/2015||Kurt Stefan Victor Clulow||Director||Buy||273,800||C$3.42||C$937,737.62|
|12/29/2015||Kurt Stefan Victor Clulow||Director||Buy||232,700||C$3.22||C$749,875.75|
|12/21/2015||Kurt Stefan Victor Clulow||Director||Buy||439,500||C$3.16||C$1,388,160.75|
|9/30/2015||Kurt Stefan Victor Clulow||Director||Buy||50,000||C$1.43||C$71,500.00|
|9/29/2015||Kurt Stefan Victor Clulow||Director||Buy||153,400||C$1.42||C$217,889.36|
|9/25/2015||Raymond Manuel Hakim||Director||Buy||15,000||C$1.69||C$25,399.50|
|9/15/2015||Andrew Trevor Bishop||Director||Buy||10,000||C$1.81||C$18,100.00|
|9/8/2015||Simon Geoffrey Best||Director||Buy||30,000||C$1.95||C$58,464.00|
|7/16/2015||Simon Geoffrey Best||Director||Buy||60,000||C$2.43||C$145,782.00|
|7/15/2015||Steven J Burton||Director||Sell||49,842||C$2.30||C$114,811.05|
|7/2/2015||Kurt Stefan Victor Clulow||Director||Buy||229,900||C$2.32||C$533,184.08|
|6/30/2015||Kurt Stefan Victor Clulow||Director||Buy||770,100||C$2.26||C$1,742,736.30|
|6/29/2015||Kurt Stefan Victor Clulow||Director||Buy||114,750||C$2.10||C$240,435.68|
|6/26/2015||Kurt Stefan Victor Clulow||Director||Buy||885,250||C$2.12||C$1,879,208.70|
|6/5/2015||Raymond Manuel Hakim||Director||Buy||50,000||C$2.45||C$122,495.00|
|2/6/2015||John Edward Moran||Director||Buy||64,500||C$1.51||C$97,395.00|
Latest Headlines for ProMetic Life Sciences (TSE:PLI)
What is ProMetic Life Sciences' stock symbol?
ProMetic Life Sciences trades on the Tornton Stock Exchange (TSX) under the ticker symbol "PLI."
Where is ProMetic Life Sciences' stock going? Where will ProMetic Life Sciences' stock price be in 2017?
8 analysts have issued twelve-month price targets for ProMetic Life Sciences' stock. Their predictions range from C$3.30 to C$5.00. On average, they expect ProMetic Life Sciences' stock price to reach C$4.57 in the next year.
When will ProMetic Life Sciences announce their earnings?
ProMetic Life Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 28th 2017.
How do I buy ProMetic Life Sciences stock?
Shares of ProMetic Life Sciences and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How much does a share of ProMetic Life Sciences stock cost?
One share of ProMetic Life Sciences stock can currently be purchased for approximately C$2.25.
ProMetic Life Sciences (TSE:PLI) Chart for Sunday, February, 26, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart